YARROW BIOSCIENCE, INC. Repayments of Long-Term Debt
YARROW BIOSCIENCE, INC. (YARW) reported Repayments of Long-Term Debt of $0 for the 12-month period ending 2022-12-31, per its 10-K filed 2023-03-14.
Discontinued › Cash Flow › Financing Activities
us-gaap:RepaymentsOfLongTermDebt · last filed 2023-03-14
- YARROW BIOSCIENCE, INC. repayments of long-term debt for the quarter ending 2022-12-31 was $0.00.
- YARROW BIOSCIENCE, INC. repayments of long-term debt for the quarter ending 2021-12-31 was $0.00.
- YARROW BIOSCIENCE, INC. repayments of long-term debt for the quarter ending 2020-12-31 was $0.00.
- YARROW BIOSCIENCE, INC. repayments of long-term debt for fiscal 2022 was $0.00, a 100.00% decline from fiscal 2021.
- YARROW BIOSCIENCE, INC. repayments of long-term debt for fiscal 2021 was $36.43M.
- YARROW BIOSCIENCE, INC. repayments of long-term debt for fiscal 2020 was $0.00.
| Period end | Repayments of Long-term Debt | Repayments of Long-term Debt 3 month | Repayments of Long-term Debt 9 month | Repayments of Long-term Debt 12 month |
|---|---|---|---|---|
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-14 | $0.00 10-K · filed 2023-03-14 | ||
| 2022-09-30 | $0.00 10-Q · filed 2022-11-14 | |||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-14 | $36.43M 10-K · filed 2023-03-14 | ||
| 2021-09-30 | $36.43M 10-Q · filed 2022-11-14 | |||
| 2021-08-11 | $36.50M 10-K · filed 2023-03-14 | |||
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-17 | $0.00 10-K · filed 2022-03-17 | ||
| 2020-09-30 | $0.00 10-Q · filed 2021-11-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B |